Reliv International was founded by Robert and Sandy Montgomery and began direct selling in 1988. The company built its business around powdered nutritional supplements, with its original flagship product, Reliv Classic, tied to the formula developed by Dr. Theodore Kalogris. Reliv later expanded into broader nutritional-support, weight-management, sports-nutrition, and healthy-aging products.
Reliv remains active as a direct-selling/network-marketing company headquartered in Chesterfield, Missouri. Current product lines include nutritional and dietary supplements for basic nutrition, specific wellness needs, weight management, and sports nutrition. Products include Reliv Classic, Reliv Now, Reliv Now for Kids, Innergize!, FibRestore, LunaRich products, ProVantage, GlucAffect, 24K, CardioSentials, and related supplement formulas.
Reliv continues to sell through independent distributors and preferred customers. Its current public disclosure describes the company as using an international network-marketing system with independent distributors in the United States and selected international markets, including Australia, New Zealand, Canada, Malaysia, Mexico, the Philippines, the United Kingdom, Ireland, France, Germany, Austria, and the Netherlands. Reliv also sells through its corporate website, direct email, texting, social media, preferred-customer channels, and an Amazon marketplace.
The company remains public but much smaller than in its earlier Nasdaq years. Reliv trades on the OTC market under the symbol RELV. In 2025, Reliv reported net sales of $20.5 million, down slightly from $21.0 million in 2024, and a net loss of $1.55 million, compared with a $1.93 million net loss in 2024. Distributor royalties and commissions were $6.39 million in 2025.
Reliv's regulatory history includes a 2024 DSSRC monitoring inquiry involving earnings claims and product-performance claims made by salesforce members on Facebook and YouTube. DSSRC recommended that Reliv discontinue several earnings and product-performance claims, including claims suggesting that participants could earn substantial income, pay off debt, or earn full-time income from the Reliv opportunity, and claims that products could improve certain health-related conditions. DSSRC reported that Reliv removed six of seven earnings-claim posts and was working to remove the remaining challenged YouTube language.
Reliv's regulatory history also includes California Proposition 65 matters involving alleged lead exposure from supplement products. In 2013, Environmental Research Center v. Reliv International, Inc. settled for $77,500, including $8,800 in civil penalties, $42,750 in attorney fees, and $25,950 as a payment in lieu of penalty, with warning or reformulation relief. A later Proposition 65 settlement dated January 5, 2026 involved allegations that Reliv distributed or sold Plant-Based Protein products in California containing lead without Proposition 65 warnings; Reliv denied wrongdoing, and the agreement resolved the disputed claims without an admission of liability.